|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 14701 to 14800 out of 22447 for Gt(ROSA)26Sor

<< First    < Previous  |  Next >    Last >>
0.101s

Categories

Hits by Category

Hits by Strain

Type Details Score
Publication
21479246 | J:171443
First Author: Goldman SJ
Year: 2011
Journal: PLoS One
Title: Use of the ODD-luciferase transgene for the non-invasive imaging of spontaneous tumors in mice.
Volume: 6
Issue: 3
Pages: e18269
•
•
•
•
•
Publication
24332913 | J:205494
First Author: Cheung KJ
Year: 2013
Journal: Cell
Title: Collective invasion in breast cancer requires a conserved basal epithelial program.
Volume: 155
Issue: 7
Pages: 1639-51
•
•
•
•
•
Publication
33263277 | J:316379
   
First Author: Kalinski AL
Year: 2020
Journal: Elife
Title: Analysis of the immune response to sciatic nerve injury identifies efferocytosis as a key mechanism of nerve debridement.
Volume: 9
•
•
•
•
•
Publication
34533976 | J:350747
First Author: Zhan Y
Year: 2021
Journal: Sci Immunol
Title: Differential requirement for the Polycomb repressor complex 2 in dendritic cell and tissue-resident myeloid cell homeostasis.
Volume: 6
Issue: 63
Pages: eabf7268
•
•
•
•
•
Strain
MGI:6392626 | STOCK Gt(ROSA)26Sor<tm3(CAG-EYFP)Hze> Trp53<tm1Brn>/Trp53<tm3Tyj> Nkx3-1<tm4(cre/ERT2)Mms> Pten<tm1Hwu>/AbshnJ
Attribute String: targeted mutation, mutant stock
•
•
•
•
•
Strain
MGI:6392622 | STOCK Brca2<tm1Brn> Gt(ROSA)26Sor<tm3(CAG-EYFP)Hze> Trp53<tm1Brn> Nkx3-1<tm4(cre/ERT2)Mms> Pten<tm1Hwu>/AbshnJ
Attribute String: targeted mutation, mutant stock
•
•
•
•
•
Strain
MGI:6392624 | STOCK Gt(ROSA)26Sor<tm3(CAG-EYFP)Hze> Trp53<tm1Brn> Nkx3-1<tm4(cre/ERT2)Mms> Pten<tm1Hwu>/AbshnJ
Attribute String: mutant stock, targeted mutation
•
•
•
•
•
Publication
35120601 | J:320538
First Author: Alam A
Year: 2022
Journal: Cancer Cell
Title: Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.
Volume: 40
Issue: 2
Pages: 153-167.e11
•
•
•
•
•
Publication
28841687 | J:263746
First Author: Buchakjian MR
Year: 2017
Journal: PLoS One
Title: A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
Volume: 12
Issue: 8
Pages: e0183469
•
•
•
•
•
Publication
36351945 | J:331101
First Author: Sodir NM
Year: 2022
Journal: Nat Commun
Title: Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution.
Volume: 13
Issue: 1
Pages: 6782
•
•
•
•
•
Publication
35508126 | J:325007
First Author: Trieu KG
Year: 2022
Journal: Cell Rep
Title: Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.
Volume: 39
Issue: 5
Pages: 110779
•
•
•
•
•
Publication
24740995 | J:217850
First Author: Caswell DR
Year: 2014
Journal: Cancer Discov
Title: Obligate progression precedes lung adenocarcinoma dissemination.
Volume: 4
Issue: 7
Pages: 781-9
•
•
•
•
•
Publication
30332632 | J:278145
First Author: Mollaoglu G
Year: 2018
Journal: Immunity
Title: The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
Volume: 49
Issue: 4
Pages: 764-779.e9
•
•
•
•
•
Publication
22340597 | J:181459
First Author: Choi N
Year: 2012
Journal: Cancer Cell
Title: Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation.
Volume: 21
Issue: 2
Pages: 253-65
•
•
•
•
•
Publication
29317452 | J:256651
     
First Author: Yang A
Year: 2018
Journal: Cancer Discov
Title: Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms.
•
•
•
•
•
Publication
34898002 | J:324239
First Author: Marazioti A
Year: 2022
Journal: EMBO Mol Med
Title: KRAS signaling in malignant pleural mesothelioma.
Volume: 14
Issue: 2
Pages: e13631
•
•
•
•
•
Publication
32286280 | J:287097
First Author: Chung PED
Year: 2020
Journal: Nat Commun
Title: Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy.
Volume: 11
Issue: 1
Pages: 1825
•
•
•
•
•
Publication
37279073 | J:338526
 
First Author: Nirala BK
Year: 2023
Journal: JCI Insight
Title: MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma.
Volume: 8
Issue: 13
•
•
•
•
•
Publication
34398873 | J:309041
First Author: Aiderus A
Year: 2021
Journal: PLoS Genet
Title: Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.
Volume: 17
Issue: 8
Pages: e1009094
•
•
•
•
•
Publication
35013174 | J:317790
First Author: Cheung PF
Year: 2022
Journal: Nat Commun
Title: Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.
Volume: 13
Issue: 1
Pages: 156
•
•
•
•
•
Publication
25497209 | J:266514
First Author: Diakopoulos KN
Year: 2015
Journal: Gastroenterology
Title: Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processes.
Volume: 148
Issue: 3
Pages: 626-638.e17
•
•
•
•
•
Publication
30905761 | J:274207
First Author: Liao W
Year: 2019
Journal: Cancer Cell
Title: KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.
Volume: 35
Issue: 4
Pages: 559-572.e7
•
•
•
•
•
Publication
31534224 | J:280631
First Author: Morris JP 4th
Year: 2019
Journal: Nature
Title: α-Ketoglutarate links p53 to cell fate during tumour suppression.
Volume: 573
Issue: 7775
Pages: 595-599
•
•
•
•
•
Publication
30885981 | J:274227
First Author: Wang J
Year: 2019
Journal: Cancer Res
Title: Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.
Volume: 79
Issue: 9
Pages: 2208-2219
•
•
•
•
•
Publication
31257023 | J:278348
First Author: Lignitto L
Year: 2019
Journal: Cell
Title: Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1.
Volume: 178
Issue: 2
Pages: 316-329.e18
•
•
•
•
•
Publication
33420244 | J:300392
First Author: Schukken KM
Year: 2021
Journal: Sci Rep
Title: Acute systemic loss of Mad2 leads to intestinal atrophy in adult mice.
Volume: 11
Issue: 1
Pages: 68
•
•
•
•
•
Publication
24497554 | J:208044
First Author: Lau AN
Year: 2014
Journal: EMBO J
Title: Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis.
Volume: 33
Issue: 5
Pages: 468-81
•
•
•
•
•
Publication
30297799 | J:266587
First Author: Sánchez-Danés A
Year: 2018
Journal: Nature
Title: A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy.
Volume: 562
Issue: 7727
Pages: 434-438
•
•
•
•
•
Publication
27643638 | J:240510
First Author: Svensson RU
Year: 2016
Journal: Nat Med
Title: Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models.
Volume: 22
Issue: 10
Pages: 1108-1119
•
•
•
•
•
Publication
28289141 | J:242160
First Author: Boutin AT
Year: 2017
Journal: Genes Dev
Title: Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.
Volume: 31
Issue: 4
Pages: 370-382
•
•
•
•
•
Publication
31833833 | J:286515
   
First Author: Yang D
Year: 2019
Journal: Elife
Title: Axon-like protrusions promote small cell lung cancer migration and metastasis.
Volume: 8
•
•
•
•
•
Publication
36577366 | J:336851
First Author: An HW
Year: 2022
Journal: Cell Rep
Title: The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer.
Volume: 41
Issue: 13
Pages: 111878
•
•
•
•
•
Publication
25203324 | J:315073
First Author: Tao J
Year: 2014
Journal: Cancer Cell
Title: Notch activation as a driver of osteogenic sarcoma.
Volume: 26
Issue: 3
Pages: 390-401
•
•
•
•
•
Publication
22493246 | J:183841
First Author: Rajurkar M
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis.
Volume: 109
Issue: 17
Pages: E1038-47
•
•
•
•
•
Publication
30996350 | J:280283
First Author: Shi Y
Year: 2019
Journal: Nature
Title: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.
Volume: 569
Issue: 7754
Pages: 131-135
•
•
•
•
•
Publication
37169967 | J:335562
     
First Author: Ely ZA
Year: 2023
Journal: Nat Biotechnol
Title: A prime editor mouse to model a broad spectrum of somatic mutations in vivo.
•
•
•
•
•
Publication
39048817 | J:357741
First Author: Park J
Year: 2024
Journal: Nature
Title: SMYD5 methylation of rpL40 links ribosomal output to gastric cancer.
Volume: 632
Issue: 8025
Pages: 656-663
•
•
•
•
•
Publication
31871154 | J:336847
First Author: Ng SR
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer.
Volume: 117
Issue: 1
Pages: 513-521
•
•
•
•
•
Publication
37059105 | J:336846
First Author: Gaglia G
Year: 2023
Journal: Cancer Cell
Title: Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma.
Volume: 41
Issue: 5
Pages: 871-886.e10
•
•
•
•
•
Publication
31358900 | J:289733
First Author: He Y
Year: 2019
Journal: Oncogene
Title: Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate.
Volume: 38
Issue: 38
Pages: 6507-6520
•
•
•
•
•
Publication
27374332 | J:234641
First Author: Denny SK
Year: 2016
Journal: Cell
Title: Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
Volume: 166
Issue: 2
Pages: 328-342
•
•
•
•
•
Publication
32046984 | J:287277
First Author: Dey P
Year: 2020
Journal: Cancer Discov
Title: Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.
Volume: 10
Issue: 4
Pages: 608-625
•
•
•
•
•
Publication
34877497 | J:318004
First Author: Zheng B
Year: 2021
Journal: iScience
Title: A new murine esophageal organoid culture method and organoid-based model of esophageal squamous cell neoplasia.
Volume: 24
Issue: 12
Pages: 103440
•
•
•
•
•
Publication
31197172 | J:278483
First Author: Shi L
Year: 2019
Journal: Nat Commun
Title: Robust elimination of genome-damaged cells safeguards against brain somatic aneuploidy following Knl1 deletion.
Volume: 10
Issue: 1
Pages: 2588
•
•
•
•
•
Publication
35322202 | J:327070
First Author: Li Q
Year: 2022
Journal: Cell Death Differ
Title: Disruption of GMNC-MCIDAS multiciliogenesis program is critical in choroid plexus carcinoma development.
Volume: 29
Issue: 8
Pages: 1596-1610
•
•
•
•
•
Publication
31257073 | J:277539
First Author: Lionarons DA
Year: 2019
Journal: Cancer Cell
Title: RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance.
Volume: 36
Issue: 1
Pages: 68-83.e9
•
•
•
•
•
Publication
32203415 | J:291404
First Author: Tsang T
Year: 2020
Journal: Nat Cell Biol
Title: Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma.
Volume: 22
Issue: 4
Pages: 412-424
•
•
•
•
•
Publication
35143422 | J:323007
 
First Author: Verhaegen ME
Year: 2022
Journal: J Clin Invest
Title: Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice.
Volume: 132
Issue: 7
•
•
•
•
•
Publication
23523371 | J:198227
First Author: Snyder EL
Year: 2013
Journal: Mol Cell
Title: Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Volume: 50
Issue: 2
Pages: 185-99
•
•
•
•
•
Publication
26748703 | J:277596
First Author: Swahari V
Year: 2016
Journal: Cell Rep
Title: Essential Function of Dicer in Resolving DNA Damage in the Rapidly Dividing Cells of the Developing and Malignant Cerebellum.
Volume: 14
Issue: 2
Pages: 216-24
•
•
•
•
•
Publication
35236758 | J:322997
 
First Author: Miyai Y
Year: 2022
Journal: Life Sci Alliance
Title: Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade.
Volume: 5
Issue: 6
•
•
•
•
•
Publication
32473656 | J:293402
First Author: Ireland AS
Year: 2020
Journal: Cancer Cell
Title: MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
Volume: 38
Issue: 1
Pages: 60-78.e12
•
•
•
•
•
Publication
28321130 | J:243873
First Author: Lu X
Year: 2017
Journal: Nature
Title: Effective combinatorial immunotherapy for castration-resistant prostate cancer.
Volume: 543
Issue: 7647
Pages: 728-732
•
•
•
•
•
Publication
29196603 | J:258374
First Author: Hsu SC
Year: 2018
Journal: J Biol Chem
Title: Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
Volume: 293
Issue: 7
Pages: 2466-2475
•
•
•
•
•
Publication
37558703 | J:338899
First Author: Hasapis S
Year: 2023
Journal: Sci Rep
Title: Characterizing the role of Phlda3 in the development of acute toxicity and malignant transformation of hematopoietic cells induced by total-body irradiation in mice.
Volume: 13
Issue: 1
Pages: 12916
•
•
•
•
•
Publication
36897957 | J:338895
First Author: Zhu Y
Year: 2023
Journal: Sci Immunol
Title: Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer.
Volume: 8
Issue: 81
Pages: eade4656
•
•
•
•
•
Publication
37257519 | J:354968
First Author: Ko KP
Year: 2023
Journal: Gastroenterology
Title: Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion.
Volume: 165
Issue: 3
Pages: 613-628.e20
•
•
•
•
•
Publication
23352126 | J:194330
First Author: Shackelford DB
Year: 2013
Journal: Cancer Cell
Title: LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
Volume: 23
Issue: 2
Pages: 143-58
•
•
•
•
•
Publication
34531315 | J:323056
First Author: Hou P
Year: 2021
Journal: Genes Dev
Title: USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer.
Volume: 35
Issue: 19-20
Pages: 1327-1332
•
•
•
•
•
Publication
24954535 | J:214523
First Author: Kapoor A
Year: 2014
Journal: Cell
Title: Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.
Volume: 158
Issue: 1
Pages: 185-197
•
•
•
•
•
Publication
27479497 | J:257776
First Author: Mann KM
Year: 2016
Journal: Nat Biotechnol
Title: Analyzing tumor heterogeneity and driver genes in single myeloid leukemia cells with SBCapSeq.
Volume: 34
Issue: 9
Pages: 962-72
•
•
•
•
•
Publication
24567396 | J:273896
First Author: Gorrini C
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway.
Volume: 111
Issue: 12
Pages: 4472-7
•
•
•
•
•
Publication
36653361 | J:332636
First Author: Ferguson LP
Year: 2023
Journal: Nat Commun
Title: Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
Volume: 14
Issue: 1
Pages: 292
•
•
•
•
•
Publication
26701088 | J:232811
First Author: Wang G
Year: 2016
Journal: Cancer Discov
Title: Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
Volume: 6
Issue: 1
Pages: 80-95
•
•
•
•
•
Publication
30712876 | J:359967
First Author: Jin C
Year: 2019
Journal: Cell
Title: Commensal Microbiota Promote Lung Cancer Development via γδ T Cells.
Volume: 176
Issue: 5
Pages: 998-1013.e16
•
•
•
•
•
Publication
39555401 | J:358444
First Author: Verstappe J
Year: 2024
Journal: iScience
Title: ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states.
Volume: 27
Issue: 11
Pages: 111169
•
•
•
•
•
Publication
29769563 | J:262736
First Author: Renard M
Year: 2018
Journal: Sci Rep
Title: Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice.
Volume: 8
Issue: 1
Pages: 7642
•
•
•
•
•
Publication
34628485 | J:322179
First Author: Humpton TJ
Year: 2022
Journal: Cell Death Differ
Title: p53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl4.
Volume: 29
Issue: 3
Pages: 514-526
•
•
•
•
•
Publication
39024561 | J:353584
 
First Author: Ku SY
Year: 2024
Journal: J Clin Invest
Title: Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer.
Volume: 134
Issue: 17
•
•
•
•
•
Publication
30415923 | J:272057
First Author: Eichner LJ
Year: 2019
Journal: Cell Metab
Title: Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models.
Volume: 29
Issue: 2
Pages: 285-302.e7
•
•
•
•
•
Publication
36604424 | J:332432
First Author: Sterling NA
Year: 2023
Journal: Nat Commun
Title: An entosis-like process induces mitotic disruption in Pals1 microcephaly pathogenesis.
Volume: 14
Issue: 1
Pages: 82
•
•
•
•
•
Publication
23230003 | J:194616
First Author: Yu Y
Year: 2012
Journal: J Exp Med
Title: Bcl11a is essential for lymphoid development and negatively regulates p53.
Volume: 209
Issue: 13
Pages: 2467-83
•
•
•
•
•
Publication
37353528 | J:337455
First Author: Pourebrahim R
Year: 2023
Journal: Cell Death Dis
Title: Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage.
Volume: 14
Issue: 6
Pages: 371
•
•
•
•
•
Publication
31462499 | J:279288
First Author: Wisdom AJ
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Neutrophils promote tumor resistance to radiation therapy.
Volume: 116
Issue: 37
Pages: 18584-18589
•
•
•
•
•
Publication
37934116 | J:360096
First Author: Saggese P
Year: 2024
Journal: Cancer Res
Title: Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma.
Volume: 84
Issue: 2
Pages: 305-327
•
•
•
•
•
Publication
30753336 | J:288706
     
First Author: Ochiai M
Year: 2019
Journal: Carcinogenesis
Title: Kras-driven heterotopic tumor development from hepatobiliary organoids.
•
•
•
•
•
Publication
34344693 | J:316038
     
First Author: Ciampricotti M
Year: 2021
Journal: Cancer Discov
Title: Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer.
•
•
•
•
•
Publication
39186687 | J:360596
First Author: MacLeod G
Year: 2024
Journal: Cancer Res
Title: Fitness Screens Map State-Specific Glioblastoma Stem Cell Vulnerabilities.
Volume: 84
Issue: 23
Pages: 3967-3983
•
•
•
•
•
Publication
38200309 | J:349030
First Author: Cho MG
Year: 2024
Journal: Nature
Title: MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis.
Volume: 625
Issue: 7995
Pages: 585-592
•
•
•
•
•
Publication
30771521 | J:349051
First Author: Lee JW
Year: 2019
Journal: J Thorac Oncol
Title: The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.
Volume: 14
Issue: 6
Pages: 1046-1060
•
•
•
•
•
Publication
38922876 | J:352925
First Author: Oikawa K
Year: 2024
Journal: J Pathol
Title: Liver-specific DICER1 syndrome model mice develop cystic liver tumors with defective primary cilia.
Volume: 264
Issue: 1
Pages: 17-29
•
•
•
•
•
Publication
30918400 | J:282897
First Author: Yao W
Year: 2019
Journal: Nature
Title: Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.
Volume: 568
Issue: 7752
Pages: 410-414
•
•
•
•
•
Publication
26567140 | J:227253
First Author: Green S
Year: 2015
Journal: Cancer Res
Title: PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Volume: 75
Issue: 24
Pages: 5378-91
•
•
•
•
•
Publication
26766588 | J:231322
First Author: Serresi M
Year: 2016
Journal: Cancer Cell
Title: Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.
Volume: 29
Issue: 1
Pages: 17-31
•
•
•
•
•
Publication
27298335 | J:233306
First Author: Kim DW
Year: 2016
Journal: Genes Dev
Title: Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer.
Volume: 30
Issue: 11
Pages: 1289-99
•
•
•
•
•
Publication
25119024 | J:217085
First Author: Viale A
Year: 2014
Journal: Nature
Title: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Volume: 514
Issue: 7524
Pages: 628-32
•
•
•
•
•
Publication
26669487 | J:227329
First Author: Giachino C
Year: 2015
Journal: Cancer Cell
Title: A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Volume: 28
Issue: 6
Pages: 730-742
•
•
•
•
•
Publication
23384338 | J:213102
First Author: Koren S
Year: 2013
Journal: FEBS J
Title: Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors.
Volume: 280
Issue: 12
Pages: 2758-65
•
•
•
•
•
Publication
32568216 | J:309362
First Author: Cochrane CR
Year: 2020
Journal: J Clin Invest
Title: Trp53 and Rb1 regulate autophagy and ligand-dependent Hedgehog signaling.
Volume: 130
Issue: 8
Pages: 4006-4018
•
•
•
•
•
Publication
29321668 | J:261042
First Author: Welcker D
Year: 2018
Journal: Oncogene
Title: AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer.
Volume: 37
Issue: 11
Pages: 1503-1518
•
•
•
•
•
Publication
31973890 | J:286259
First Author: Olivero CE
Year: 2020
Journal: Mol Cell
Title: p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.
Volume: 77
Issue: 4
Pages: 761-774.e8
•
•
•
•
•
Publication
27803059 | J:237522
First Author: Lang PY
Year: 2016
Journal: Development
Title: ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.
Volume: 143
Issue: 21
Pages: 4038-4052
•
•
•
•
•
Publication
36006995 | J:330132
First Author: Gao X
Year: 2022
Journal: Cancer Res
Title: Notch Signaling Promotes Mature T-Cell Lymphomagenesis.
Volume: 82
Issue: 20
Pages: 3763-3773
•
•
•
•
•
Publication
29990309 | J:266426
First Author: Knauf JA
Year: 2018
Journal: J Clin Invest
Title: Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.
Volume: 128
Issue: 9
Pages: 4086-4097
•
•
•
•
•
Publication
28099846 | J:254560
First Author: Nagaraj AS
Year: 2017
Journal: Cell Rep
Title: Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1.
Volume: 18
Issue: 3
Pages: 673-684
•
•
•
•
•
Publication
27558455 | J:241617
 
First Author: Cammareri P
Year: 2016
Journal: Nat Commun
Title: Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma.
Volume: 7
Pages: 12493
•
•
•
•
•
Publication
37845394 | J:343060
First Author: Vaghjiani VG
Year: 2023
Journal: Oncogene
Title: Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.
Volume: 42
Issue: 47
Pages: 3529-3541
•
•
•
•
•
Publication
32025000 | J:291017
First Author: Sethi NS
Year: 2020
Journal: Nat Genet
Title: Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.
Volume: 52
Issue: 2
Pages: 219-230
•
•
•
•
•
Publication
21764851 | J:174756
First Author: Dooley AL
Year: 2011
Journal: Genes Dev
Title: Nuclear factor I/B is an oncogene in small cell lung cancer.
Volume: 25
Issue: 14
Pages: 1470-5
•
•
•
•
•
Publication
27459053 | J:233597
First Author: Sánchez-Danés A
Year: 2016
Journal: Nature
Title: Defining the clonal dynamics leading to mouse skin tumour initiation.
Volume: 536
Issue: 7616
Pages: 298-303
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom